Lactulose Breath Testing Can Be a Positive Predictor Before Weight Gain in Participants with Obesity Submitted to Roux-en-Y Gastric Bypass
- 46 Downloads
Small intestinal bacterial overgrowth (SIBO) is defined as the colonization of fermentative bacteria in the duodenum and jejunum. The alteration of digestive anatomy promoted by bariatric surgery may be a pre-disposing factor for SIBO. In this context, the prevalence of SIBO in participants undergoing bariatric surgery using Roux-en-Y gastric bypass (BGYR) was evaluated.
Participants, both sexes, older than 18 years, were those who (a) had bariatric surgery by the BGYR technique at least 1 year before the data collection and (b) did not use antibiotics recently. The SIBO diagnosis was established through the hydrogen breath test (H2BT), with intake of lactulose and serial collection of breath samples over 2 h. A test with ≥ 12-point elevation over the basal sample at 60 min after substrate intake was deemed positive.
A total of 18 participants (14 females (77.8%)) were enrolled with a mean age of 50.5 years (range, 23 to 79 years). The interval between surgery and data collection ranged from 5 to 20 years (mean, 11.2 years). The mean preoperative body mass index (BMI) was 44.6 kg/m2 (range, 36.7–56.2 kg/m2). The H2RT with lactulose was positive for SIBO in seven (six female) participants. The participants with negative test measured trough H2BT with lactulose had a lower mean BMI of 28.69 kg/m2, in comparison with the positive group, which presented a mean BMI of 33.04 kg/m2 (p value = 0.041).
Our data point to a high prevalence of SIBO (38.8%) in patients undergoing BGYR with a value in accordance with the literature. Moreover, the differences in BMI between negative and positive groups by H2BT with lactulose evidenced a weight gain relapse in participants with SIBO.
KeywordsBacterial overgrowth Bariatric surgery Breath test Lactulose Obesity Small intestine
All authors have approved the manuscript and agreed with its submission. Moreover, LKC, NSC, TNR, and PJCC idealized the project; collected patients’ data; worked on supervision, realization, and validation based on repeatability of the exams; contribute with the safety analysis; conducted the writing and critical review of the study; FALM conducted the writing and critical review of the study, also, performed the statistical analysis of the data. All authors have contributed to manuscript writing.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
The project was approved by the research ethics committee from the institution.
Informed consent was obtained from each participant.
- 2.Fried M, Yumuk V, Oppert JM, et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55.CrossRefGoogle Scholar
- 12.Roland BC, Lee D, Miller LS, et al. Obesity increases the risk of small intestinal bacterial overgrowth (SIBO). Neurogastroenterol Motil. 2018;7:303–9.Google Scholar
- 14.Bulanda M, Gosiewski T, Brzychczy-Włoch M. Small intestinal bacterial overgrowth in adult patients with type 1 diabetes. Pol Arch Med Wewn. 2016;126:623–4.Google Scholar
- 18.Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (NY). 2007;3:112–22.Google Scholar
- 20.Gasbarrini A, Corazza GR, Gasbarrini G, et al. 1st Rome H2-breath testing consensus conference working group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome consensus conference. Aliment Pharmacol Ther. 2009;29:1–49.Google Scholar
- 22.Newberry C, Tierney A, Pickett-Blakely O. Lactulose hydrogen breath test result is associated with age and gender. Bio Med Res Int. 2016;2016:10640291–5.Google Scholar
- 26.Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412–9.Google Scholar
- 50.Scarpelini E, Giorgio V, Gabrielli M. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case control study. J Pediatr. 2009;46:4574–82.Google Scholar
- 53.Sabaté JM, Coupaye M, Ledoux S, et al. Consequences of small intestinal bacterial overgrowth in obese patients before and after bariatric surgery. Obes Surg. 2016;16:2343–5.Google Scholar
- 54.Fialho A, Thota P, McCullough AJ, et al. Small intestinal bacterial overgrowth is associated with non-alcoholic fatty liver disease. J Gastrointestin Liver Dis. 2016;25:159–65.Google Scholar